These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 785461

  • 21. Evaluation of corticosteroid therapy for acute renal allograft rejection.
    Vineyard GC, Fadem SZ, Dmochowski J, Carpenter CB, Wilson RE.
    Surg Gynecol Obstet; 1974 Feb; 138(2):225-9. PubMed ID: 4589909
    [No Abstract] [Full Text] [Related]

  • 22. Rejection episodes and patient and graft survival after renal transplantation.
    Finkelstein FO, Lytton B, Schiff M, Black HR.
    Clin Nephrol; 1975 Jun; 3(6):217-9. PubMed ID: 1095270
    [Abstract] [Full Text] [Related]

  • 23. Kidney transplantation for patients with diabetes mellitus.
    Najarian JS, Henriksen AI, Simmons RL, Kjellstrand CM.
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):121-7. PubMed ID: 4612898
    [No Abstract] [Full Text] [Related]

  • 24. [Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].
    Matl I, Lácha J, Lodererová A, Símová M, Teplan V, Lánská V, Vítko S.
    Cas Lek Cesk; 2000 Mar 01; 139(4):115-9. PubMed ID: 10838741
    [Abstract] [Full Text] [Related]

  • 25. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
    Kumano K, Irie A, Mashimo S, Endo T, Koshiba K.
    Transplant Proc; 1996 Jun 01; 28(3):1354-5. PubMed ID: 8658691
    [No Abstract] [Full Text] [Related]

  • 26. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H, Haussman G, Isaacs I, Ishitani M, Lobo P, McCullough C, Pruett T.
    Clin Transplant; 1997 Oct 01; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [Abstract] [Full Text] [Related]

  • 27. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP, Messina M, Colla L, Piccoli GB, Triolo G, Vercellone A.
    Transplant Proc; 1988 Jun 01; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract] [Full Text] [Related]

  • 28. Long term survival and graft function after cadaver kidney transplantation.
    Lund F, Thaysen JH, Ladefoged J, Nerstrom B.
    Acta Chir Scand Suppl; 1976 Jun 01; 472():9-12. PubMed ID: 801100
    [Abstract] [Full Text] [Related]

  • 29. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E, Robinson C, Bear R.
    Transplant Proc; 1989 Feb 01; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract] [Full Text] [Related]

  • 30. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients.
    Hricik DE, Seliga RM, Fleming-Brooks S, Bartucci MR, Schulak JA.
    Clin Transplant; 1995 Oct 01; 9(5):419-23. PubMed ID: 8541637
    [Abstract] [Full Text] [Related]

  • 31. Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids.
    Hardy KW, Crocker JF, McLellan H, Goralski KB, Renton KW, Acott PD.
    J Clin Pharmacol; 2005 Feb 01; 45(2):161-7. PubMed ID: 15647408
    [Abstract] [Full Text] [Related]

  • 32. Review of human renal transplantation at the Toronto General Hospital.
    Farrow GA, Wilson DR, Fenton SS, Hayman WP.
    Can J Surg; 1973 Mar 01; 16(2):134-8. PubMed ID: 4570266
    [No Abstract] [Full Text] [Related]

  • 33. Alternative immunosuppressive strategies in the management of recipients of living related renal transplants.
    Hodge E, Banowsky L, Novick A, Lewis R, Streem S, Steinmuller D, Holzmann J, McFarlin L, Graneto D, Medendorp SV.
    Transplant Proc; 1989 Feb 01; 21(1 Pt 2):1609-14. PubMed ID: 2652524
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of chronic allograft rejection.
    Fan Y, Xie T, Xu D, Wang XH, Jin WH.
    Chin Med J (Engl); 1993 Jul 01; 106(7):497-9. PubMed ID: 8243119
    [Abstract] [Full Text] [Related]

  • 35. Rescue of severe steroid-resistant rejection with OKT3.PAN.
    Ponticelli C, Rivolta E, Tarantino A, De Vecchi A, Vegeto A.
    Transplant Proc; 1987 Feb 01; 19(1 Pt 3):1908-9. PubMed ID: 3274449
    [No Abstract] [Full Text] [Related]

  • 36. Experience in human renal allotransplantation.
    Woods JE, DeWeerd JH, Johnson WJ, Anderson CF, Shorter RG.
    Surg Gynecol Obstet; 1972 Mar 01; 134(3):394-8. PubMed ID: 4551193
    [No Abstract] [Full Text] [Related]

  • 37. Sequential clinical and immunological follow-up shows similar evolution during the first trimester after renal transplantation in patients receiving azathioprine or not.
    Renowt E, Béne C, Hestin D, Karleskind I, Faure G, Kessler M.
    Clin Nephrol; 1992 Oct 01; 38(4):235-6. PubMed ID: 1424315
    [No Abstract] [Full Text] [Related]

  • 38. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
    van Gelder T, Zietse R, Yzermans JN, Rischen-Vos J, Vaessen LM, Weimar W.
    Transplant Proc; 1996 Dec 01; 28(6):3221-2. PubMed ID: 8962247
    [No Abstract] [Full Text] [Related]

  • 39. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 40. [Cortisone cataract after renal transplantation].
    Mahlich J, Thiel G, Dobrivojevic D, Brunner F, Enderlin F.
    Dtsch Med Wochenschr; 1972 Jun 02; 97(22):860-5. PubMed ID: 4555724
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.